UiPath (PATH) Stock Plunges Nearly 8% on Light Trading Despite Revenue Beat

Key Takeaways

Table of Contents

UiPath stock declined 7.7% on Wednesday, reaching an intraday bottom of $11.00 from its previous close of $12.04.
Trading volume was exceptionally light, coming in 85% below typical session volume.
The majority of analysts maintain a “Hold” rating on PATH with an average price target of $13.80.
The company’s most recent quarterly revenue totaled $418.38 million, representing a 17.3% increase year-over-year and exceeding expectations.
Convergence Investment Partners established a fresh $4.4 million stake in PATH during the first quarter.

Shares of UiPath (PATH) plummeted 7.7% during Wednesday’s trading session, briefly hitting an intraday bottom of $11.00 before closing at $11.11. This represents a sharp decline from the previous session’s close of $12.04.

UiPath Inc., PATH

The most notable aspect of Wednesday’s decline was the remarkably low trading activity. Approximately 6.4 million shares traded hands — a staggering 85% below the stock’s typical daily volume of 41.4 million shares. Such limited liquidity can often amplify price movements beyond what might occur under normal trading conditions.

Currently, PATH’s 50-day moving average rests at $11.11, while its 200-day moving average sits at $11.75. The company maintains a market capitalization of roughly $5.50 billion.

Analyst Sentiment Remains Neutral

Wall Street’s outlook on PATH leans conservative. Among 17 analysts tracking the stock, 14 have assigned it a “Hold” rating, while two recommend “Buy” and one maintains a “Sell.” The average price target across all analysts stands at $13.80.

Recent analyst activity has skewed toward the bearish side. BMO Capital Markets lowered its price target from $14 to $13 while maintaining a “market perform” stance. Morgan Stanley reduced its target from $17 to $15 with an “equal weight” rating. UBS decreased its target from $13 to $12, retaining a “neutral” outlook. Bank of America marginally increased its target from $12 to $13 but continues to rate the stock “underperform.”

Needham stands out as the most bullish voice, maintaining a “buy” rating with a $15 price objective.

Strong Quarterly Results Defied the Selloff

Wednesday’s decline appears disconnected from fundamentals, as PATH delivered impressive results in its late May earnings report. The company generated $418.38 million in revenue, comfortably surpassing Wall Street’s estimate of $397.54 million. This marked a solid 17.3% increase compared to the same period last year.

Earnings per share registered at $0.15, precisely meeting analyst expectations. The comparable quarter in the previous year produced $0.11 EPS. The company achieved a net margin of 19.58% and a return on equity of 7.92%.

Looking ahead, Wall Street analysts project full-year earnings of $0.40 per share.

The stock’s 52-week range spans from a low of $9.20 to a high of $19.84 — placing Wednesday’s close significantly below its peak performance over the trailing twelve months.

From an institutional ownership perspective, Convergence Investment Partners established a new position during Q1, acquiring 396,363 shares valued at roughly $4.4 million, representing approximately 0.08% of the company. Overall, institutional investors hold 62.50% of UiPath’s outstanding shares.

Additional smaller investment firms initiated positions in Q4, including HighMark Wealth Management, Raleigh Capital Management, and Atlas Capital Advisors, though each position valued less than $40,000.

PATH concluded Wednesday’s session at $11.11, hovering right at its 50-day moving average level.

✨ Limited Time Offer